Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Legal Guidelines for Documentation

Legal Guidelines for Documentation

The legal guidelines for nursing documentation are essential for ensuring accurate, professional, and ethical recording of patient care. The guidelines are discussed here:

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...

Sources of Law

Sources of Law

Laws form the essential rules set by governing authorities to shape and control societal behavior. In nursing, laws guide actions, safeguard patient rights, define nurses' scope of practice, and maintain professional standards. Understanding the legal framework governing nursing involves recognizing four primary sources of law: constitutional, statutory, administrative (regulatory), and common law.
Constitutional law is foundational, deriving from federal and state constitutions, and...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

Global Regulatory Systems

Global Regulatory Systems

Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...

Scientific Laws and Theories

Scientific Laws and Theories

Scientific Laws

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Relaxation oscillations and frequency entrainment in quantum mechanics.

Physical review. E·2020

Same author

Phase-Preserving Linear Amplifiers Not Simulable by the Parametric Amplifier.

Physical review letters·2020

Same author

Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial.

Journal of clinical pharmacy and therapeutics·2017

Same author

Coherent chemical kinetics as quantum walks. I. Reaction operators for radical pairs.

Physical review. E·2016

Same author

Coherent chemical kinetics as quantum walks. II. Radical-pair reactions in Arabidopsis thaliana.

Physical review. E·2016

Same author

Clinical value of electrophysiology in determining the diagnosis of visual dysfunction in neuro-ophthalmology patients.

Documenta ophthalmologica. Advances in ophthalmology·2015

Search research articles

Related Experiment Videos

Legal foundations of adaptive licensing.

K Oye¹, L G Baird, A Chia

¹Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. oye@mit.edu

Clinical Pharmacology and Therapeutics

|August 22, 2013

Summary

This summary is machine-generated.

Legal experts confirmed existing statutes support adaptive pharmaceuticals licensing (AL) across major regulatory bodies. However, Health Canada identified gaps, while reimbursement during AL was deemed legally consistent.

Related Experiment Videos

Area of Science:

Biomedical innovation
Pharmaceutical regulation
Legal frameworks for drug approval

Background:

A 2012 workshop convened by MIT and the European Medicines Agency (EMA) addressed legal foundations for adaptive pharmaceuticals licensing (AL).
Participants included legal experts from the US Food and Drug Administration (FDA), EMA, Health Sciences Agency Singapore (HSA), and Health Canada.
The workshop aimed to assess the legal viability of AL strategies.

Framework:

Attorneys from the FDA, EMA, and HSA concluded that current statutes adequately authorize adaptive licensing.
A representative from Health Canada identified specific legal gaps hindering AL implementation in their jurisdiction.
This suggests a need for legislative or regulatory adjustments in some regions to fully enable AL.

Implementation:

The legal authority for adaptive licensing was a key focus of the workshop discussions.
The feasibility of implementing AL was evaluated based on existing legal structures.
Differing legal interpretations were noted between North American and European/Asian regulatory bodies.

Implications:

Existing legal frameworks in the US, EU, and Singapore appear sufficient for adaptive licensing.
Potential legal barriers to adaptive licensing exist in Canada, requiring further review.
Reimbursement policies during the initial phases of adaptive licensing were found to be consistent with current statutes across all discussed jurisdictions.